NFE2L2 and breast carcinoma: A mechanistic investigation conducted on a panel of breast cancer cells (and other types of tumors) revealed that NRF2 was able to directly bind to the RON promoter and repress its genetic induction, while, accordingly, the reconstituted expression of NRF2 not only decreased the RON levels but, also, impaired breast cancer cell migration and invasion.